FDA issues updated list of devices subject to tracking rules

03/31/2014 | Regulatory Focus

The FDA has released a document updating the list of devices that must be tracked under the final rule setting up a unique identifier system for medical technologies. The agency said it determines whether a device should be tracked based on the technology's potential for sudden, catastrophic failure; possibility for substantial adverse clinical outcomes; and the need for immediate professional intervention.

View Full Article in:

Regulatory Focus

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN